Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Carboprost Methylate Timing in Artificial Abortion
NCT05834361Completed
- Sponsor
- Peking Union Medical College Hospital
- Start
- Jan 2022
- Primary completion
- Dec 2022
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label trial of Carboprost Methylate (2 arms), sponsored by Peking Union Medical College Hospital. Primary endpoint: Total adverse events. Started Jan 2022; status: completed.
02
Drugs
Carboprost Methylate
Beyond the preview
Go deeper on NCT05834361.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05834361.